US 2021/0196674 A1 · Therapeutics for Malaria

Abstract

The present disclosure describes a composition and method for treating and preventing malaria. The disclosure describes a peroxybioflavonoid composition comprising an artemisinin compound and one or more bioflavonoid compounds.

Claims1

Dependent claims

A method for treating, suppressing, or preventing malaria in a subject in need thereof, the method comprising the step of administering to the subject a composition comprising an Artemisinin compound and one or more bioflavonoid compounds for at least 16 consecutive days.

Dependencies are inferred from the claim text.

Facts

Application

17/197,001Filed 9 Mar 2021

Priority

22 Sep 2015

Published

1 Jul 2021

Term ends

Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 31/357
Having oxygen as the only ring hetero atom, e.g. fungichromin: having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
A61K 9/127
Dispersions; Emulsions: synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
A61K 31/365
Having oxygen as the only ring hetero atom, e.g. fungichromin: lactones
A61K 31/366
Lactones: having six-membered rings, e.g. delta-lactones

Therapeutics for Malaria

Life of this patent

Abstract

Claims1

Therapeutics for Malaria

Life of this patent

Abstract

Claims1